Kishimoto, T., Kojima, Y., & Fujimoto, N. (2021). Significance of secretory leukocyte peptidase inhibitor in pleural fluid for the diagnosis of benign asbestos pleural effusion. Nature Portfolio.
Style de citation Chicago (17e éd.)Kishimoto, Takumi, Yoko Kojima, et Nobukazu Fujimoto. Significance of Secretory Leukocyte Peptidase Inhibitor in Pleural Fluid for the Diagnosis of Benign Asbestos Pleural Effusion. Nature Portfolio, 2021.
Style de citation MLA (8e éd.)Kishimoto, Takumi, et al. Significance of Secretory Leukocyte Peptidase Inhibitor in Pleural Fluid for the Diagnosis of Benign Asbestos Pleural Effusion. Nature Portfolio, 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.